InChI=1S/C30H47N3O9S/c1- 2- 3- 4- 5- 6- 7- 8- 9- 10- 11- 12- 13- 16- 25(24(34) 15- 14- 17- 27(36) 37) 43- 21- 23(29(40) 32- 20- 28(38) 39) 33- 26(35) 19- 18- 22(31) 30(41) 42/h6- 7,9- 13,16,22- 25,34H,2- 5,8,14- 15,17- 21,31H2,1H3,(H,32,40) (H,33,35) (H,36,37) (H,38,39) (H,41,42) /b7- 6- ,10- 9+,12- 11+,16- 13+/t22- ,23- ,24- ,25+/m0/s1 |
GWNVDXQDILPJIG-CCHJCNDSSA-N |
S([C@@H]([C@@H](O)CCCC(O)=O)/C=C/C=C/C=C/C/C=C\CCCCC)C[C@H](NC(=O)CC[C@H](N)C(O)=O)C(=O)NCC(O)=O |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
View more via ChEBI Ontology
(5S,6R,7E,9E,11E,14Z)- 6- {[(2R)- 2- [(4S)- 4- amino- 4- carboxybutanamido]- 2- [(carboxymethyl)carbamoyl]ethyl]sulfanyl}- 5- hydroxyicosa- 7,9,11,14- tetraenoic acid
|
HMDB
|
11-trans-LTC4
|
HMDB
|
5S-Hydroxy-6R-(S-glutathionyl)-7E,9E,11E14Z-eicosatetraenoate
|
HMDB
|
5S-Hydroxy-6R-(S-glutathionyl)-7E,9E,11E14Z-eicosatetraenoic acid
|
HMDB
|
[R- [R*,S*- (E,E,E,Z)]]- N- [S- [1- (4- carboxy- 1- hydroxybutyl)- 2,4,6,9- pentadecatetraenyl]- N- L- g- glutamyl- L- cysteinyl]- Glycine
|
HMDB
|
[R- [R*,S*- (E,E,E,Z)]]- N- [S- [1- (4- carboxy- 1- hydroxybutyl)- 2,4,6,9- pentadecatetraenyl]- N- L- gamma- glutamyl- L- cysteinyl]- Glycine
|
HMDB
|
Leukotriene C2
|
HMDB
|
74841-69-3
|
CAS Registry Number
|
KEGG COMPOUND
|
20671299
|
PubMed citation
|
Europe PMC
|
3023351
|
PubMed citation
|
Europe PMC
|
|